强生（JNJ）股价与投研分析
Johnson & Johnson · 美国市场 · 医药健康
关键指标
- 最新价
- USD 276.32
- 日内涨跌
- +3.81%
- 市值
- USD 6651.88 亿
- 市盈率 TTM
- 41.99
- 市净率
- 8.16
- 52 周最高
- USD 282.02
- 52 周最低
- USD 185.12
- 股息率
- 1.94%
- 成交量
- 股 962.22 万
- 上市市场
- 美国
公司概况
强生（英文名 Johnson & Johnson，股票代码 JNJ）在美国市场上市， 属于医药健康行业，当前处于成熟阶段。核心标签：制药、医疗器械、高股息。
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
AI 三层投研框架
- 宏观周期层：利率、通胀、汇率与流动性如何影响美国市场的估值中枢。
- 行业格局层：用 PEST、波特五力与产业链位置判断医药健康行业的利润分配。
- 公司质地层：把 强生 的增速、利润率、ROE 与现金流放进同行业横向对比。
需要完整报告？回到终端 可基于真实财报数据生成三层 AI 分析。